Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut
Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.
It might feel like the artificial intelligence train has left the station, but there are still opportunities to get in before the boom gets even bigger.
Nevada’s Supreme Court upheld the state’s ban on ghost guns Thursday, overturning a lower court’s ruling that had sided with a gun manufacturer’s argument the 2021 law regulating firearm parts with no serial numbers was unconstitutionally vague.